Caplight Logo









Solence

Solence

Private
StrasbourgHealthcare & Life Scienceshttps://www.solence.care/

Last Round

Seed

Jul 10, 2025

Total Funding Raised

$1.87M

Momentum Score

50 /100

Company Overview

Solence is a healthcare technology company that provides a digital health support tool for the management of polycystic ovary syndrome, enabling women to better understand and manage their condition.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Medical Devices, Telemedicine, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Keywords

Polycystic Ovary SyndromePCOSPCOS managementFemTechwomen's healthdigital therapeuticDTxsubscription modelchronic condition managementdirect-to-consumerdigital health appD2Clifestyle managementsymptom trackingB2B2Cinsurance reimbursement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Solence Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Solence Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 10, 2025

Key People

Founding team and executive leadership

Julien Molinaro

CTO Late Founder

Founding Team

Julien Alary

CTO (Transition)

Executive Team

Solence Investors

Notable investors and investment history

InvestorRounds
Impact Shakers VenturesSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 1208% MoM, reaching 1.2K.

  • May 1, 2026

    Grew 50% QoQ, from 8 to 12 employees.

Solence Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Solence Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Solence's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Employee Range12
Year Founded2022
Last FundingJul 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.